Divis Laboratories reports 9% growth in Q3FY17 net profit

06 Feb 2017 Evaluate

Divis Laboratories has reported results for third quarter ended December 31, 2016. 

The company has reported 8.74% rise in its net profit at Rs 268.32 crore for the quarter under review as compared to Rs 246.76 crore for the same quarter in the previous year. Total income of the company increased by 13.84% at Rs 994.95 crore for the quarter under review as compared to Rs 873.98 crore for the corresponding quarter previous year.

Divis Laboratories focussed on developing new processes for the production of Active Pharma Ingredients (APIs) & Intermediates. The company in a matter of short time expanded its breadth of operations to provide complete turnkey solutions to the domestic Indian pharmaceutical industry.

Divis Lab Share Price

6473.35 2.75 (0.04%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×